Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
46 hedge funds and large institutions have $91.9M invested in Tobira Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 4 closing their positions.
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
4.07% less ownership
Funds ownership: 63.82% → 59.75% (-4.1%)
4% less funds holding
Funds holding: 48 → 46 (-2)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
23% less capital invested
Capital invested by funds: $120M → $91.9M (-$27.7M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$4.42M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$669K |
| 3 |
State Street
Boston,
Massachusetts
|
+$210K |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$196K |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$120K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$5.86M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$1.43M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.17M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$844K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$596K |
TBRA Hedge Fund Activity: Q1 2016 in Review
46 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q1 2016, worth a combined $91.9M — down 23% from $120M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TBRA and 2 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 16 added.
The largest buyer was Franklin Resources, opening a new position worth an estimated $4.42M. The largest seller was Sabby Management, cutting an estimated $5.86M.
- 46 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q1 2016, down from 48 in Q4 2015.
- Funds reported $91.9M of Tobira Therapeutics, Inc. Common Stock stock for Q1 2016, down 23% quarter-over-quarter.
- 2 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q1 2016 and 4 closed out, a net change of -2 holders.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q1 2016 was Franklin Resources, an estimated $4.42M added.
- The largest Tobira Therapeutics, Inc. Common Stock seller in Q1 2016 was Sabby Management, an estimated $5.86M sold.
Based on aggregated 13F filings for Q1 2016.